|
Name |
3-[(2S,5R,6R)-6-[(Z,4R,6S)-4,6-dimethyloct-2-en-2-yl]-5-methyloxan-2-yl]-4-hydroxy-5-(4-hydroxyphenyl)-1-methylpyridin-2-one
|
| Molecular Formula | C28H39NO4 | |
| IUPAC Name* |
3-[(2S,5R,6R)-6-[(Z,4R,6S)-4,6-dimethyloct-2-en-2-yl]-5-methyloxan-2-yl]-4-hydroxy-5-(4-hydroxyphenyl)-1-methylpyridin-2-one
|
|
| SMILES |
CC[C@H](C)C[C@@H](C)/C=C(/C)\[C@H]1[C@@H](CC[C@H](O1)C2=C(C(=CN(C2=O)C)C3=CC=C(C=C3)O)O)C
|
|
| InChI |
InChI=1S/C28H39NO4/c1-7-17(2)14-18(3)15-20(5)27-19(4)8-13-24(33-27)25-26(31)23(16-29(6)28(25)32)21-9-11-22(30)12-10-21/h9-12,15-19,24,27,30-31H,7-8,13-14H2,1-6H3/b20-15-/t17-,18+,19+,24-,27+/m0/s1
|
|
| InChIKey |
FVYDVAOTXPELMH-DBCNXVKXSA-N
|
|
| Synonyms |
Sambutoxin; 160047-56-3
|
|
| CAS | NA | |
| PubChem CID | 134158439 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 453.6 | ALogp: | 5.7 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 7 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 70.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 33 | QED Weighted: | 0.481 |
| Caco-2 Permeability: | -4.66 | MDCK Permeability: | 0.00001600 |
| Pgp-inhibitor: | 0.518 | Pgp-substrate: | 0.413 |
| Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.857 |
| 30% Bioavailability (F30%): | 0.617 |
| Blood-Brain-Barrier Penetration (BBB): | 0.222 | Plasma Protein Binding (PPB): | 98.41% |
| Volume Distribution (VD): | 0.336 | Fu: | 1.70% |
| CYP1A2-inhibitor: | 0.165 | CYP1A2-substrate: | 0.954 |
| CYP2C19-inhibitor: | 0.867 | CYP2C19-substrate: | 0.875 |
| CYP2C9-inhibitor: | 0.515 | CYP2C9-substrate: | 0.961 |
| CYP2D6-inhibitor: | 0.173 | CYP2D6-substrate: | 0.604 |
| CYP3A4-inhibitor: | 0.414 | CYP3A4-substrate: | 0.641 |
| Clearance (CL): | 7.912 | Half-life (T1/2): | 0.117 |
| hERG Blockers: | 0.289 | Human Hepatotoxicity (H-HT): | 0.926 |
| Drug-inuced Liver Injury (DILI): | 0.838 | AMES Toxicity: | 0.183 |
| Rat Oral Acute Toxicity: | 0.448 | Maximum Recommended Daily Dose: | 0.924 |
| Skin Sensitization: | 0.723 | Carcinogencity: | 0.092 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.023 |
| Respiratory Toxicity: | 0.848 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003004 | ![]() |
1.000 | D0O6GC | ![]() |
0.244 | ||
| ENC004957 | ![]() |
0.798 | D0QC3M | ![]() |
0.244 | ||
| ENC004958 | ![]() |
0.731 | D02LTL | ![]() |
0.240 | ||
| ENC002822 | ![]() |
0.586 | D08GHB | ![]() |
0.236 | ||
| ENC002361 | ![]() |
0.538 | D0Z1WA | ![]() |
0.235 | ||
| ENC005829 | ![]() |
0.438 | D0H6QU | ![]() |
0.235 | ||
| ENC005616 | ![]() |
0.361 | D03KIA | ![]() |
0.234 | ||
| ENC005193 | ![]() |
0.352 | D0I0DL | ![]() |
0.233 | ||
| ENC004038 | ![]() |
0.327 | D04XEG | ![]() |
0.228 | ||
| ENC002814 | ![]() |
0.326 | D0JE2E | ![]() |
0.228 | ||